Safety Results from the United States Cohort of the Ibrutinib Early Access Treatment Protocol (EAP: MCL4001) in Patients with Relapsed or Refractory Mantle Cell Lymphoma

被引：0
|
作者：
Martin, Peter [1 ]
Goy, Andre [2 ]
Ramchandren, Radhakrishnan [3 ]
Ferrante, Lucille [4 ]
Reddy, Vijay [4 ]
Londhe, Anil [4 ]
Wildgust, Mark [5 ]
McGowan, Tracy [4 ]
Bartlett, Nancy L. [6 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[3] Karmanos Canc Ctr, Detroit, MI USA
[4] Janssen Sci Affairs LLC, Horsham, PA USA
[5] Janssen Global Serv, Raritan, NJ USA
[6] Washington Univ, Sch Med, St Louis, MO USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Ibrutinib Combined with Venetoclax in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results from the Randomized Phase 3 Sympatico Study
    Wang, Michael
    Jurczak, Wojciech
    Trneny, Marek
    Belada, David
    Wrobel, Tomasz
    Ghosh, Nilanjan
    Keating, Mary-Margaret
    van Meerten, Tom
    Fernandez Alvarez, Ruben
    von Keudell, Gottfried
    Thieblemont, Catherine
    Peyrade, Frederic
    Andre, Marc
    Hoffmann, Marc
    Glusman, Edith Szafer
    Lin, Jennifer
    Dean, James P.
    Neuenburg, Jutta K.
    Tam, Constantine S.
    BLOOD, 2024, 144 : LBA5 - LBA5
  • [32] COST-EFFECTIVENESS ANALYSIS FOR ACALABRUTINIB IN THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (R/R MCL) IN CHINA
    Chang, S.
    He, X.
    VALUE IN HEALTH, 2024, 27 (06) : S95 - S95
  • [33] A phase II study of 90Yttrium-ibritumomab (Zevalin) for the treatment of patients with relapsed and refractory mantle cell lymphoma (MCL).
    Younes, A
    Pro, B
    Delpassand, E
    McLaughlin, P
    Romaguera, J
    Wang, M
    BLOOD, 2003, 102 (11) : 406A - 406A
  • [34] Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Krekeler, G.
    Herzberg, C.
    Dreyling, M.
    Hess, G.
    Kalanovic, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S850 - S851
  • [35] Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Krekeler, G.
    Dreyling, M.
    Hess, G.
    Kalanovic, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 144 - 145
  • [36] Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis
    Rule, Simon
    Dreyling, Martin
    Goy, Andre
    Hess, Georg
    Auer, Rebecca
    Kahl, Brad
    Hernandez-Rivas, Jose-Angel
    Qi, Keqin
    Deshpande, Sanjay
    Parisi, Lori
    Wang, Michael
    HAEMATOLOGICA, 2019, 104 (05) : E211 - E214
  • [37] Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Krekeler, G.
    Neuhof, A.
    Dreyling, M.
    Hess, G.
    Kalanovic, D.
    Oncology Research and Treatment, 2015, 38 : 66 - 67
  • [38] Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Krekeler, G.
    Neuhof, A.
    Dreyling, M.
    Hess, G.
    Kalanovic, D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S656 - S656
  • [39] Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
    Krekeler, G.
    Herzberg, C.
    Dreyling, M.
    Hess, G.
    Kalanovic, D.
    ONKOLOGIE, 2013, 36 : 139 - 140
  • [40] Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma
    Alegre, Adrian
    de la Rubia, Javier
    Sureda Balari, Anna
    Encinas Rodriguez, Cristina
    Suarez, Alexia
    Jesus Blanchard, Maria
    Bargay Lleonart, Joan
    Rodriguez-Otero, Paula
    Insunza, Andres
    Palomera, Luis
    Jesus Penarrubia, Maria
    Rios-Tamayo, Rafael
    Casado Montero, Luis Felipe
    Sonia Gonzalez, Marta
    Potamianou, Anna
    Couturier, Catherine
    Pei, Huiling
    Hevia, Henar
    Milionis, Iordanis
    Gaudig, Maren
    Mateos, Maria-Victoria
    HEMASPHERE, 2020, 4 (03):
12345